White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation-Reference-Cited by-同舟云学术

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

Published:2018-03-15 Issue:1 Volume:10 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Teunissen Charlotte E.^ORCID,Otto Markus,Engelborghs Sebastiaan,Herukka Sanna-Kaisa,Lehmann Sylvain,Lewczuk Piotr,Lleó Alberto,Perret-Liaudet Armand,Tumani Hayrettin,Turner Martin R.,Verbeek Marcel M.,Wiltfang Jens,Zetterberg Henrik,Parnetti Lucilla,Blennow Kaj

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-018-0359-x.pdf

Reference53 articles.

1. Zerr I, Zafar S, Schmitz M, Llorens F. Cerebrospinal fluid in Creutzfeldt-Jakob disease. Handb Clin Neurol. 2017;146:115–24.

2. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17(2):162–73.

3. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.

4. Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain. 2013;136:2419–31.

5. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367:795–804.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An improved method for sampling and quantitative protein analytics of cerebrospinal fluid of single mice;2024-06-22

2. Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer’s disease;Expert Review of Molecular Diagnostics;2023-11-03

3. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease;Nature Communications;2023-09-13

4. Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery;Journal of Proteome Research;2023-08-22

5. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2023-07